アステラス製薬株式会社(東京)。2024年売上約1.7兆円。Xospata(白血病)、Veozbh(子宮筋腫)、PADCEV(エンホフトゥマブ ベドチン, ADC)。遺伝子治療、ミトコンドリア治療プラットフォーム。
ABCR GmbH
@abcr
Medtronic plc (Dublin, Ireland / Minneapolis, MN). Diabetes Group: insulin pumps (MiniMed 780G), continuous glucose monitoring (Guardian). 2024 diabetes revenue ~$2.5B. Drug delivery chemistry, biosensors.
中触媒新材料股份有限公司(大连)。2024年营收约5亿。环保催化剂: 柴油SCR催化剂、VOCs催化氧化。分子筛: ZSM-5, TS-1, SAPO-34。钛硅分子筛(丙烯环氧化)。特种催化材料。
The lipid-based formulation improved oral bioavailability by 5-fold for this API.
Endo International plc (Dublin, Ireland). Acquired by Pharma & Co. (2024). Supprelin, Xiaflex, Lidoderm. Generic sterile injectables. Par Pharmaceutical generics. Specialty: urology, orthopedics.
Our co-factor regeneration system eliminated the need for expensive NADPH.
The GC-MS method achieved baseline separation of all 16 PAH priority pollutants.
The twin-screw extruder provided excellent mixing for our hot-melt granulation.